Madhya Pradesh reports first H3N2 infection, patient in home isolation

Madhya Pradesh Medical Education Minister Vishwas Sarang on Thursday confirmed that the first case of H3N2 infection had been reported in the state capital, Bhopal

flu
ANI
2 min read Last Updated : Mar 17 2023 | 7:41 AM IST

Madhya Pradesh Medical Education Minister Vishwas Sarang on Thursday confirmed that the first case of H3N2 infection had been reported in the state capital, Bhopal.

He informed further that the patient has been kept in home isolation.

Seasonal influenza is an acute respiratory tract infection caused by 4 distinct types of viruses -- Influenza A, B, C and D belonging to the Orthomyxoviridae family.

Among these types, Influenza A is the most common pathogen for humans.

Globally, influenza cases are typically seen to increase during certain months of the year. India usually witnesses two peaks of seasonal influenza one from January to March and another one in the post-monsoon season.

According to the Union Health Ministry, the cases arising from seasonal influenza are expected to decline from March end.

In most cases, the disease is self-limiting with symptoms of cough and cold, body ache and fever etc. and usually resolves within a week or so.

However, potentially high-risk groups such as infants, young children, pregnant women, elderly above the age of 65 years and people with comorbidities might experience more symptomatic illnesses requiring hospitalization also.

Disease transmission is mostly airborne from person to person, through large droplets generated by the act of coughing and sneezing. Other modes of transmission, include indirect contact by touching a contaminated object or surface (fomite transmission), and close contact including handshaking.

The Union Health Ministry has prescribed Oseltamivir as the drug recommended by the World Health Organization (WHO) for curing the infection.

"The drug is made available through the Public Health System free of cost. The government has allowed the sale of Oseltamivir under Schedule H1 of the Drug and Cosmetic Act in February 2017 for wider accessibility and availability," it said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Madhya PradeshBhopal

First Published: Mar 17 2023 | 7:41 AM IST

Next Story